Total Payments
$237,613
2024 Payments
$7,199
Companies
16
Transactions
118
Medicare Patients
29
Medicare Billing
$2,443
Payment Breakdown by Category
Other$139,172 (58.6%)
Consulting$50,033 (21.1%)
Research$37,574 (15.8%)
Travel$8,383 (3.5%)
Food & Beverage$2,451 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $134,422 | 14 | 56.6% |
| Consulting Fee | $50,033 | 14 | 21.1% |
| Unspecified | $37,574 | 4 | 15.8% |
| Travel and Lodging | $8,383 | 38 | 3.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,750 | 1 | 2.0% |
| Food and Beverage | $2,451 | 47 | 1.0% |
Payments by Type
General
$200,039
114 transactions
Research
$37,574
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Institute for Transfusion Medicine | $115,594 | 8 | $0 (2017) |
| GENZYME CORPORATION | $43,359 | 51 | $0 (2024) |
| BIOVERATIV THERAPEUTICS INC. | $37,574 | 4 | $0 (2018) |
| Haemonetics Corporation | $13,516 | 6 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $9,124 | 10 | $0 (2020) |
| ABLYNX NV | $7,588 | 10 | $0 (2018) |
| Grifols Shared Services North America, Inc. | $5,221 | 10 | $0 (2019) |
| Kaneka Pharma America LLC | $3,097 | 1 | $0 (2020) |
| ABLYNX US | $2,067 | 2 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $248.86 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,199 | 13 | GENZYME CORPORATION ($7,172) |
| 2023 | $22.48 | 1 | GENZYME CORPORATION ($22.48) |
| 2022 | $21,088 | 23 | GENZYME CORPORATION ($20,994) |
| 2021 | $8,425 | 3 | Haemonetics Corporation ($4,750) |
| 2020 | $21,398 | 15 | SANOFI-AVENTIS U.S. LLC ($9,035) |
| 2019 | $16,533 | 33 | Haemonetics Corporation ($5,866) |
| 2018 | $47,247 | 17 | BIOVERATIV THERAPEUTICS INC. ($37,574) |
| 2017 | $115,701 | 13 | Institute for Transfusion Medicine ($115,594) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 2 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/17/2022 | GENZYME CORPORATION | — | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| 06/17/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $70.00 | General |
| 06/17/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 06/17/2022 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $36.86 | General |
| 06/17/2022 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $35.00 | General |
| 06/17/2022 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $32.00 | General |
| 06/17/2022 | GENZYME CORPORATION | — | Food and Beverage | Cash or cash equivalent | $1.50 | General |
| 05/11/2022 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| 05/11/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $117.93 | General |
| 05/07/2022 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $65.24 | General |
| Category: Hematology | ||||||
| 05/05/2022 | GENZYME CORPORATION | ENJAYMO (Biological), CABLIVI | Food and Beverage | In-kind items and services | $49.36 | General |
| Category: Hematology | ||||||
| 05/04/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $58.28 | General |
| 12/01/2021 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 04/20/2021 | GENZYME CORPORATION | CABLIVI (Biological) | Consulting Fee | Cash or cash equivalent | $3,575.00 | General |
| Category: Hematology | ||||||
| 03/16/2021 | Haemonetics Corporation | TEG6s HEMOSTASIS SYSTEM (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,750.00 | General |
| Category: Devices | ||||||
| 12/18/2020 | Kaneka Pharma America LLC | LIPOSORBER (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $3,097.00 | General |
| Category: Lipid Apheresis | ||||||
| 11/12/2020 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,475.00 | General |
| 07/23/2020 | Haemonetics Corporation | Plasma (Device) | Consulting Fee | Cash or cash equivalent | $2,900.00 | General |
| Category: Devices | ||||||
| 04/28/2020 | GENZYME CORPORATION | CABLIVI (Biological) | Consulting Fee | Cash or cash equivalent | $3,850.00 | General |
| Category: Hematology | ||||||
| 04/03/2020 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Hematology | ||||||
| 01/20/2020 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Immunology | ||||||
| 01/08/2020 | SANOFI-AVENTIS U.S. LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,786.00 | General |
| 01/08/2020 | SANOFI-AVENTIS U.S. LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,930.03 | General |
| 01/08/2020 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | In-kind items and services | $523.16 | General |
| 01/08/2020 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | In-kind items and services | $515.25 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 3, Pivotal, Open-label, Multicenter Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion | BIOVERATIV THERAPEUTICS INC. | $18,787 | 2 |
| A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfu | BIOVERATIV THERAPEUTICS INC. | $18,787 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 13 | 14 | $3,514 | $1,118 |
| 2020 | 1 | 16 | 16 | $4,016 | $1,325 |
Total Patients
29
Total Services
30
Medicare Billing
$2,443
Procedure Codes
2
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 13 | 14 | $3,514 | $1,118 | 31.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 16 | 16 | $4,016 | $1,325 | 33.0% |
About Joseph Kiss
Joseph Kiss is a Specialist healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871567065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joseph Kiss has received a total of $237,613 in payments from pharmaceutical and medical device companies, with $7,199 received in 2024. These payments were reported across 118 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($134,422).
As a Medicare-enrolled provider, Kiss has provided services to 29 Medicare beneficiaries, totaling 30 services with total Medicare billing of $2,443. Data is available for 2 years (2020–2021), covering 2 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Pittsburgh, PA
- Active Since 02/14/2006
- Last Updated 05/24/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1871567065
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $37,574
- CABLIVI (Drug) $14,889
- CABLIVI (Biological) $12,657
- Plasma (Device) $8,766
- TEG6s HEMOSTASIS SYSTEM (Device) $4,750
- Albutein (Biological) $4,192
- LIPOSORBER (Device) $3,097
- ENJAYMO (Biological) $2,839
- Flebogamma DIF (Biological) $1,124
- SOLIRIS (Drug) $139.62
- XARELTO (Drug) $29.22
- ERLEADA (Drug) $26.32
- JADENU (Drug) $22.18
- PROMACTA (Drug) $20.86
- Ultomiris (Drug) $15.83
- ELIQUIS (Drug) $15.81
- CHANTIX (Drug) $14.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Pittsburgh
Dr. Lawrence Crossett, Md, MD
Specialist — Payments: $5.3M
Specialist $5.3M
Dr. James Bradley, Md, MD
Specialist — Payments: $5.0M
Specialist $5.0M
Darrell Triulzi
Specialist — Payments: $3.3M
Specialist $3.3M
Dr. Mark Yazer, Md, MD
Specialist — Payments: $2.4M
Specialist $2.4M
Lirong Qu
Specialist — Payments: $2.4M
Specialist $2.4M
Dr. Miguel Regueiro, Md, MD
Specialist — Payments: $1.4M
Specialist $1.4M